中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

FibroTouch检测肝硬度值及脂肪衰减值的稳定性分析

赵晓博 于静 张振华 邹桂舟

引用本文:
Citation:

FibroTouch检测肝硬度值及脂肪衰减值的稳定性分析

DOI: 10.3969/j.issn.1001-5256.2020.01.023
基金项目: 

安徽省自然科学基金(1608085MH162); 

详细信息
  • 中图分类号: R575.2;R575.5

Stability of FibroTouch in determining liver stiffness measurement and controlled attenuation parameter

Research funding: 

 

  • 摘要: 目的探讨FibroTouch(FT)检测肝硬度值(LSM)及脂肪衰减值(CAP)的稳定性。方法选择2018年11月20日-2019年1月14日安徽医科大学第二附属医院肝病科门诊行FT检测的慢性HBV感染者(n=177)、非酒精性脂肪性肝病(NAFLD)患者(n=56)、肝功能异常患者(n=34)以及其他疾病患者(n=42)共309例,对同一受检者的3个不同测量点进行FT检测,运用组内相关系数(ICC)、Bland-Altman法评价测量值的稳定性;运用Kendall’s W检验、饼状图评价诊断结果的稳定性。结果同一受测者的3个不同测量点检测的LSM值和CAP值在不同疾病组的ICC均> 0. 75(P值均<0. 001),其中慢性HBV感染者组的LSM值ICC最大,为0. 905;其他疾病组的CAP值的ICC最大,为0. 805;而NAFLD组的LSM值和CAP值的ICC均最小,分别为0. 785、0. 780; 3个测量点之间分别绘制Bland-Altman图,一致性限度内的点均维持在95%左右。通过分析,3个测量点的LSM分期及CAP分期的诊断结果的Kendall’s W...

     

  • [1] SCHMELTZER PA,TALWALKAR JA. Noninvasive tools to assess hepatic fibrosis:Ready for prime time?[J]. Gastroenterol Clin North Am,2011,40(3):507-521.
    [2] KEMP W,LEVY M,WELTMAN M,et al. Australian Liver Association(ALA)expert consensus recommendations for the use of transient elastography in chronic viral hepatitis[J]. J Gastroenterol Hepatol,2015,30(3):453-462.
    [3] SANDRIN L,FOURQUET B,HASQUENOPH JM,et al. Transient elastography:A new noninvasive method for assessment of hepatic fibrosis[J]. Ultrasound Med Biol,2003,29(12):1705-1713.
    [4] XIAO CH,WANG WH,WANG WF,et al. Value of Fibrotouch and Fibroscan in the detection of liver tissue elastic modulus[J]. Beijing Med J,2014,36(3):202-205.(in Chinese)夏长虹,王文欢,王伟芳,等.Fibrotouch与Fibroscan检测肝脏硬度的临床效能比较[J].北京医学,2014,36(3):202-205.
    [5] CENG J,SUN WY,CHEN GY,et al. Efficiency of FibroScan and FibroTouch in liver stiffness measurement and fat quantification:A comparative analysis[J]. Chin J Hepatol,2016,24(9):652-658.(in Chinese)曾静,孙婉璐,陈光榆,等.FibroTouch与FibroScan肝脏硬度和脂肪定量检测效能的比较[J].中华肝脏病杂志,2016,24(9):652-658.(in Chinese)
    [6] Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese,Medical Association. The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol,2015,31(12):1941-1960.中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
    [7] National Workshop on Fatty Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association;Fatty Liver Expert Committee,Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease:A 2018 update[J]. J Clin Hepatol,2018,34(5):947-957.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年版)[J].临床肝胆病杂志,2018,34(5):947-957.
    [8] CAO JB,CHEN YP,CHENG J,et al. Expert consensus on clinical application of transient elastic imaging(TE)(2015)[J/CD]. Chin J Liver Dis(Electr Version),2015,7(2):12-18.(in Chinese)曹建彪,陈永平,成军,等.瞬时弹性成像技术(TE)临床应用专家共识(2015年版)[J/CD].中国肝脏病杂志(电子版),2015,7(2):12-18.
    [9] YU HM,LUO YH,SA J,et al. Intraclass correlation coefficient and software procedures[J]. Chin J Health Statistics,2011,28(5):497-500.(in Chinese)余红梅,罗艳虹,萨建,等.组内相关系数及其软件实现[J].中国卫生统计,2011,28(5):497-500.
    [10] WEN H,LU MJ. Consistency evaluation for quantitative measurements by Bland-Altman method and its clinical application[J]. J Med Postgraduates,2015,28(10):1107-1111.(in Chinese)闻浩,陆梦洁.定量测量Bland-Altman一致性评价方法研究及临床应用[J].医学研究生学报,2015,28(10):1107-1111.
    [11] LI HX,LUO Q,ZHANG R,et al. Test of Kendall coefficient of concordance W and the implementation of programs[J]. Chin J Hospital Statistics,2013,20(3):170-173.(in Chinese)李洪兴,罗庆,张荣,等.肯德尔和谐系数W检验及程序实现[J].中国医院统计,2013,20(3):170-173.
    [12] CHANG TT,LIAW YF,WU SS,et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B[J]. Hepatology,2010,52(3):886-893.
    [13] ROCKEY DC. Fibrosis reversal after hepatitis C virus elimination[J]. Curr Opin Gastroenterol,2019,35(3):137-144.
    [14] CZAJA AJ. Review article:The prevention and reversal of hepatic fibrosis in autoimmune hepatitis[J]. Aliment Pharmacol Ther,2014,39(4):385-406.
    [15] DHAMIJA E,PAUL SB,KEDIA S. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma:An increasing concern[J]. Indian J Med Res,2019,149(1):9-17.
    [16] STARLEY BQ,CALCAGNO CJ,HARRISON SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma:A weighty connection[J]. Hepatology,2010,51(5):1820-1832.
    [17] WU N,ZHANG MY,WU RH,et al. Diagnostic values of FibroScan and FibroTouch for liver fibrosis:A comparative analysis[J]. J Clin Hepatol,2014,30(7):624-627.(in Chinese)吴娜,张明媛,吴瑞红,等.FibroScan与FibroTouch对肝纤维化程度诊断价值的比较分析[J].临床肝胆病杂志,2014,30(7):624-627.
    [18] YANG XZ,GEN AW,XIAN JC,et al. Diagnostic value of various noninvasive indexes in the diagnosis of chronic hepatic fibrosis[J]. Eur Rev Med Pharmacol Sci,2018,22(2):479-485.
    [19] WANG RT,TAN Q,LIU L,et al. Study on the diagnostic value of abdominal ultrasonography combined with fibrotouch in fatty liver of adolescents[J]. J Imag Res Med Appl,2019,3(9):27-28.(in Chinese)王荣桃,谭青,刘磊,等.腹部B超联合FibroTouch在青少年脂肪肝诊断价值的研究[J].影像研究与医学应用,2019,3(9):27-28.
    [20] SHEN F,ZHENG RD,SHI JP,et al. Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease[J]. Liver Int,2015,35(11):2392-2400.
  • 加载中
计量
  • 文章访问数:  1477
  • HTML全文浏览量:  71
  • PDF下载量:  241
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-07-19
  • 出版日期:  2020-01-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回